Epimedium is a genus of flowering plants native to China and parts of Asia and Europe, best known in the West by its nickname “horny goat weed.” It has been used in traditional Chinese medicine for centuries, primarily as a tonic for sexual health, bone strength, and fatigue. Today it’s one of the most popular herbal supplements marketed for male performance, though its effects extend well beyond that single use.
The Plant Behind the Name
Epimedium belongs to the barberry family and includes more than 50 species found in China alone. Five of those species are officially listed in the Chinese Pharmacopoeia as medicinal: E. sagittatum, E. pubescens, E. brevicornu, E. koreanum, and E. wushanense. In practice, more than 20 species are used interchangeably in herbal preparations. The leaves are the part used medicinally, harvested and typically dried or processed into extracts.
The plant itself is a low-growing perennial with heart-shaped leaves, often grown as ornamental ground cover in temperate gardens. Its colorful, spurred flowers bloom in spring. But the commercial interest is almost entirely in what the leaves contain chemically.
Icariin: The Key Active Compound
The most studied compound in epimedium is a flavonoid called icariin. It’s the most abundant active ingredient in the plant and serves as the standard marker for quality control in epimedium supplements. When you take icariin orally, intestinal bacteria convert about 91% of it into a more active form called icariside II.
Icariin works through several mechanisms at once. It inhibits an enzyme called PDE5, the same target that prescription erectile dysfunction drugs block. However, natural icariin is far weaker at this than pharmaceutical options. In lab studies, chemically modifying icariin boosted its PDE5-blocking ability 80-fold, bringing it close to the potency of prescription drugs. That gives you a sense of the gap between the supplement and the medication.
Where icariin may have a unique edge is in nerve support. Lab research found that icariin significantly enhanced nerve fiber growth in tissue samples, something that prescription PDE5 inhibitors did not accomplish in the same experiments. This neurotrophic (nerve-supporting) property is distinct from what conventional drugs offer, though it has only been demonstrated in lab settings so far.
Icariin also increases production of nitric oxide, a molecule that relaxes blood vessels. It does this by activating the enzyme responsible for nitric oxide in blood vessel walls, both boosting the enzyme’s activity and increasing the amount of it cells produce. This vasodilating effect connects to several of epimedium’s proposed benefits, from sexual function to cardiovascular health.
Sexual Health Effects
Epimedium’s reputation as an aphrodisiac is its main selling point in the supplement market. Animal studies using various doses of icariin and its active metabolite (typically ranging from 1 to 200 mg/kg body weight) have shown improvements in erectile function across multiple models of dysfunction. The effect appears dose-dependent, with lower to moderate doses generally performing better than very high ones.
The mechanisms go beyond simple PDE5 inhibition. By increasing nitric oxide availability and potentially supporting nerve tissue in the pelvic region, icariin acts on erectile function from multiple angles. That said, robust human clinical trials remain limited. Most of the evidence comes from animal research and cell studies, which means the strength of the effect in people, and the dose needed to achieve it, is still not well established.
Bone Health and Osteoporosis
One of epimedium’s most promising applications is in bone health, particularly for postmenopausal osteoporosis. The plant contains several compounds, including flavonoids and phytoestrogens like genistein and daidzein, that influence bone metabolism through multiple pathways. These compounds promote the activity of bone-building cells while reducing the activity of cells that break bone down.
A systematic review and meta-analysis of clinical data found that epimedium, used alongside conventional osteoporosis treatment, significantly improved bone mineral density, treatment effectiveness, and pain scores compared to conventional treatment alone. Even more notably, epimedium used by itself improved bone mineral density and reduced pain more effectively than conventional therapy in some comparisons. Patients taking epimedium alone also showed better markers of bone metabolism, including lower levels of alkaline phosphatase, an enzyme that rises with excessive bone turnover.
The review suggested that epimedium works best as an add-on therapy when used for longer than three months, and as a standalone treatment when used for three months or less. Decoctions (traditional boiled preparations) appeared to deliver more benefit than other dosage forms, possibly due to differences in how the active compounds are extracted and absorbed.
Cardiovascular and Anti-Inflammatory Effects
Icariin shows anti-inflammatory and antioxidant properties that are relevant to heart and blood vessel health. In lab studies, icariin protected blood vessel lining cells from damage caused by oxidized LDL cholesterol, which is one of the early steps in plaque buildup. It reduced the ability of immune cells to stick to blood vessel walls and lowered the production of adhesion molecules that facilitate that process. All of these effects were dose-dependent: more icariin produced greater protection.
These findings suggest a potential role in preventing or slowing atherosclerosis, but the evidence is currently limited to cell and animal studies. No large human trials have tested epimedium specifically for cardiovascular disease prevention.
Effects on Stress Hormones
Epimedium flavonoids appear to help counteract the suppressive effects of glucocorticoids (stress hormones or steroid medications) on the body’s hormonal stress response system. In animal research, rats given corticosterone experienced significant drops in body weight, adrenal gland size, and circulating stress hormone levels. When epimedium flavonoids were added alongside the corticosterone, body weight, adrenal gland size, and natural corticosterone production were partially restored.
This is relevant for people taking corticosteroid medications long-term, as these drugs can suppress the body’s ability to produce its own stress hormones. The research suggests epimedium flavonoids may buffer against that suppression without interfering with the medication’s therapeutic effects, though this has only been tested in animals.
Safety Concerns and Side Effects
Epimedium is generally considered safe at typical supplement doses, but adverse reactions have been documented. Reported side effects include rapid heart rate and hypomania (an elevated, agitated mood state) after two weeks of use, abdominal pain, and nausea. One case report described increased opiate cravings in a patient taking buprenorphine for opioid dependence.
A more serious case involved a 33-year-old man who went to the emergency department with severe muscle spasms lasting 10 hours after taking epimedium. His creatine kinase, a marker of muscle damage, rose to over three times the normal upper limit and didn’t return to normal until seven days later. His kidney function markers were also elevated. This appears to be the first documented case of this specific reaction.
Because icariin inhibits PDE5 and promotes nitric oxide production, it could theoretically interact with blood pressure medications or nitrate drugs used for heart conditions, amplifying their blood-pressure-lowering effects.
Supplement Quality Is a Real Problem
One of the biggest practical risks with epimedium supplements isn’t the herb itself. It’s what manufacturers sometimes add to it. In May 2025, the FDA announced a voluntary recall of a horny goat weed product after testing revealed it was laced with sildenafil and a sildenafil analogue, neither of which was listed on the label. These are pharmaceutical-grade drugs that can cause dangerous drops in blood pressure when combined with nitrate medications commonly prescribed for heart disease.
This is not an isolated incident. The FDA has repeatedly flagged sexual enhancement supplements, including those marketed as herbal, for containing undeclared pharmaceutical ingredients. Because dietary supplements in the United States are not subject to pre-market approval, the burden falls on the consumer to choose reputable brands that conduct third-party testing. If a supplement produces effects that feel noticeably pharmaceutical, such as rapid onset of action or strong side effects, that’s a reason to be suspicious of what’s actually in the capsule.
What to Know Before Taking It
There is no standardized human dose for epimedium. Animal studies have used a wide range of icariin doses, but translating those to human equivalents is not straightforward. Supplements on the market vary enormously in icariin content and are often standardized to different percentages, with some listing total flavonoid content rather than icariin specifically. Without consistent human dosing data, choosing a dose is largely guesswork.
The strongest evidence for epimedium’s benefits exists in bone health, where clinical data supports its use alongside or as an alternative to conventional osteoporosis treatments. Its sexual health effects are plausible based on its mechanisms but remain poorly validated in human trials. Its cardiovascular and hormonal effects are promising in the lab but preliminary. If you’re considering epimedium, look for products from manufacturers that provide certificates of analysis from independent labs, and be cautious about products making aggressive performance claims.